DALLAS, Texas - BeaconEquity.com announces the publication of “China Biopharma (CHBO) Issues Update of its Operations.”
Investors can view all of the investment articles for free by visiting: http://www.beaconequity.com/m - Click on News and Commentary
In the article the author writes:
"China Biopharma Inc. (OTCBB: CHBO), the China-based pharmaceutical, released an update of the company’s operations to investors and other interested parties.”
China Biopharma expects profitability to increase as a result of its restructuring efforts:
“China Biopharma has improved its corporate restructuring initiated in 2007 as a plan by management to increase efficiencies and profitability. Revenue for the first nine months of 2008 ended September 30, 2008, jumped approximately 1,200% to $5.4 million, compared with approximately $400,000 revenue for the comparable period last year. A net profit for the nine-month period of fiscal 2008 was approximately $90,000, compared with a loss of nearly $(350,000) for last year equivalent period.”
To read the entire article visit http://www.beaconequity.com/m – Click on News and Commentary
Join the fastest growing investor community at: http://www.stockhideout.com/
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting:
http://www.beaconequity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505